Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation

about

Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation

Item

http://www.wikidata.org/entity/Q37664313

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Lymphocyte-specific protein 1 ...... ressing ERK1/2 phosphorylation

@en

Lymphocyte-specific protein 1 ...... essing ERK1/2 phosphorylation.

@nl

type

Item

label

Lymphocyte-specific protein 1 ...... ressing ERK1/2 phosphorylation

@en

Lymphocyte-specific protein 1 ...... essing ERK1/2 phosphorylation.

@nl

prefLabel

Lymphocyte-specific protein 1 ...... ressing ERK1/2 phosphorylation

@en

Lymphocyte-specific protein 1 ...... essing ERK1/2 phosphorylation.

@nl

P1476

Lymphocyte-specific protein 1 ...... ressing ERK1/2 phosphorylation

@en

P2093

Bowen Yao

http://www.w3.org/2001/XMLSchema#string

Changwei Dou

http://www.w3.org/2001/XMLSchema#string

Hongyong Zhang

http://www.w3.org/2001/XMLSchema#string

Meng Xu

http://www.w3.org/2001/XMLSchema#string

Qing Li

http://www.w3.org/2001/XMLSchema#string

Qingguang Liu

http://www.w3.org/2001/XMLSchema#string

Shengli Wu

http://www.w3.org/2001/XMLSchema#string

Yufeng Wang

http://www.w3.org/2001/XMLSchema#string

Yuli Jia

http://www.w3.org/2001/XMLSchema#string

Zhikui Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments

Long noncoding RNAs in cancer: mechanisms of action and technological advancements

Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment

Regulatory Roles of MAPK Phosphatases in Cancer

Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism

Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton

Crucial role for the LSP1-myosin1e bimolecular complex in the regulation of Fcγ receptor-driven phagocytosis

Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.

Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.

Identification of leukocyte-specific protein 1-positive cells: a clue to the cell of origin and a marker for the diagnosis of dermatofibroma.

P304

1227-1237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/2211-5463.12139

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kangsheng Tu

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28255535

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

lymphocyte

P932

5324767

http://www.w3.org/2001/XMLSchema#string